NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 341 filers reported holding NEKTAR THERAPEUTICS in Q2 2019. The put-call ratio across all filers is 2.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $162,000 | -60.1% | 30,062 | 0.0% | 0.00% | -57.1% |
| Q4 2021 | $406,000 | -24.8% | 30,062 | 0.0% | 0.01% | -30.0% |
| Q3 2021 | $540,000 | +4.7% | 30,062 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $516,000 | -14.1% | 30,062 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $601,000 | +280.4% | 30,062 | +539.6% | 0.01% | +233.3% |
| Q1 2019 | $158,000 | -64.2% | 4,700 | -50.0% | 0.00% | -40.0% |
| Q4 2018 | $441,000 | +53.7% | 9,400 | +100.0% | 0.01% | -16.7% |
| Q3 2018 | $287,000 | +15.3% | 4,700 | -7.8% | 0.01% | +20.0% |
| Q2 2018 | $249,000 | – | 5,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |